Effect of coadministration of enriched Korean Red Ginseng (Panax ginseng) and American ginseng (Panax quinquefolius L) on cardiometabolic outcomes in type-2 diabetes: A randomized controlled trial
Elena Jovanovski,Lea Smircic-Duvnjak,Allison Komishon,Fei Au-Yeung,John L. Sievenpiper,Andreea Zurbau,Alexandra L. Jenkins,Mi-Kyung Sung,Robert Josse,Dandan Li,Vladimir Vuksan,Fei (Rodney) Au-Yeung
DOI: https://doi.org/10.1016/j.jgr.2019.11.005
IF: 5.735
2021-09-01
Journal of Ginseng Research
Abstract:BackgroundDiabetes mellitus and hypertension often occur together, amplifying cardiovascular disease (CVD) risk and emphasizing the need for a multi-targeted treatment approach. American (AG) and Korean red ginseng (KRG) species could improve glycemic control via complementary mechanisms. Additionally, a KRG-inherent component, ginsenoside Rg3, may moderate blood pressure (BP). Our objective was to investigate the therapeutic potential of co-administration of Rg3-enriched Korean Red Ginseng (Rg3-KRG) and AG, added to standard of care therapy, in the management of hypertension and cardiometabolic risk factors in type 2 diabetes.MethodsWithin a randomized, controlled, parallel design of 80 participants with type 2 diabetes (HbA1c: 6.5-8%) and hypertension (systolic BP:140-160 mmHg or treated), supplementation with either 2.25g/day of combined Rg3-KRG+AG or wheat-bran control was assessed over a 12-week intervention period. The primary endpoint was ambulatory 24-hour systolic BP. Additional endpoints included further hemodynamic assessment, glycemic control, plasma lipids and safety monitoring.ResultsCombined ginseng intervention generated a mean±SE decrease in primary endpoint of 24-h systolic BP (-3.98±2.0 mmHg, p=0.04). Additionally, there was a greater reduction in HbA1c (-0.35±0.1% [-3.8±1.1 mmol/mol], p=0.02), and change in blood lipids: total cholesterol (-0.50±0.2 mmol/l, p=0.01), non-HDL-C (-0.54±0.2 mmol/l, p=0.01), triglycerides (-0.40±0.2 mmol/l, p=0.02) and LDL-C (-0.35±0.2 mmol/l, p=0.06) at 12-weeks, relative to control. No adverse safety outcomes were observed.ConclusionCo-administration of Rg3-KRG+AG is an effective add-on for improving BP along with attaining favorable cardiometabolic outcomes in individuals with type 2 diabetes. Ginseng derivatives may offer clinical utility when included in the polypharmacy and lifestyle treatment of diabetes.
chemistry, medicinal,integrative & complementary medicine